{"duration": 0.02417898178100586, "input_args": {"text": "'Daily Mail October 27, 2016 As entertainment firms fight to stay ahead of virtual and augmented reality systems, Netflix CEO Reed Hastings is keeping tabs on hallucinogenic drugs. At the Wall Street Journal Live conference on Tuesday, Hastings discussed potential challenges the streaming service may face in the future, including \u2018pharmacological\u2019 competition. The chief executive went on to describe a Matrix-like scenario in which users could take a \u2018blue pill\u2019 to experience hallucinatory entertainment and a \u2018white pill\u2019 to come back to reality \u2013 and says it could happen in the next twenty years. \\nAt the WSJ conference, Hastings explained that the firm is working hard to draw users\u2019 attention away from apps, social media, and other major competitors, TechCrunch reports.   8:48  '"}, "time": 1742561823.109097}